Insider Transactions Reported | 10x Genomics(TXG)saw insider trading activity on 8/26/2025

10x Genomics(TXG) saw insider trading activity on 8/26/2025, there were 3 insider trades during the day.

【History Insider Transaction】

Declare date	Position	Name	Buy/Sell	Quantity	Price per share/USD	Total Amount/USD
8/26/2025	Chief Executive Officer	Saxonov Serge	Sell	9348	13.79	128.88k
8/26/2025	President and Chief Scientific Officer	Hindson Benjamin J.	Sell	7486	13.79	103.21k
8/26/2025	Chief Financial Officer	Taich Adam	Sell	22315	13.79	307.66k
5/27/2025	Chief Financial Officer	Taich Adam	Sell	4044	8.30	33.56k
5/27/2025	Chief Executive Officer	Saxonov Serge	Sell	9343	8.30	77.54k
5/27/2025	President and Chief Scientific Officer	Hindson Benjamin J.	Sell	7485	8.30	62.12k
3/4/2025	Chief Executive Officer	Saxonov Serge	Sell	7942	10.63	84.39k
3/4/2025	Chief Executive Officer	Saxonov Serge	Buy	50000	1.20	60.0k
2/26/2025	Chief Executive Officer	Saxonov Serge	Sell	5092	11.07	56.35k
2/26/2025	President and Chief Scientific Officer	Hindson Benjamin J.	Sell	4573	11.07	50.6k

[Company Profile]
10x Genomics, Inc. was incorporated in the state of Delaware on July 2, 2012. The Company began commercial and manufacturing operations and selling its instruments and consumables in 2015. The Company's integrated solutions include the Company's Chromium instruments, which are referred to as “instruments”, its enzymes, reagents, microfluidic chips and other consumable products, which are referred to as “consumables”, and software for analyzing biological systems.